Anavex Life Sciences will target Asia for the use of blarcamesine for the treatment of Alzheimer's disease and/or dementia.
After it has been approved and successfully used in some initial jurisdiction one can only guess for whom and where in the world blarcamesine would next be used.
When that happens, when blarcamesine is being successfully and safely used in one country, how long will it take for this to be known elsewhere? What will be the new media headlines? "New Drug in Outer Slobovia Safely, Successfully Treats Alzheimer's."
Will public responses be, "Well that's really nice?"